NEW YORK, Dec. 29, 2010 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:
The Outlook for Pharmaceuticals in Western Europe
http://www.reportlinker.com/p0203107/The-Outlook-for-Pharmaceuticals-in-Western-Europe.html
The countries of Western Europe represent a total market of over
365 million people and a combined GDP of US$14.4 trillion in
2007.
The 11 main Western European markets for pharmaceuticals are
wealthy and mature. Is there any point in manufacturers trying to
break into markets they are not already servicing, and, if yes,
where? If they are already operating in the region, what are the
prospects for growth and what operating environment will they face
in the future?
Valuable markets…
News stories chronicle the pressures and problems facing
governments trying to expand or maintain health provision in a
cost-constrained world. But one fact remains. The countries covered
by this report represent a total pharmaceutical market value of
US$206.2 billion. We forecast this figure will grow by US$38.4
billion over the next five years to US$244.6 billion.
…with cost pressures
All health funders are experiencing difficulties in meeting the
demands on modern health systems. Pressures arise from many
quarters including:
The cost of current branded medicines which is leading to
accelerated growth in generic usage in key markets such as Spain
and France
The often high cost of new therapies which provide marginal
therapeutic benefit
An ageing population needing longer and more intensive medical
treatments
Unplanned population increase due to immigrat
‘/>”/>
SOURCE